Investigating and Comparing the Association of Fatty Liver with Tamoxifen and Letrozole in Premenopausal Patients with Breast Cancer - Trial IRCT20221126056616N1
Access comprehensive clinical trial information for IRCT20221126056616N1 through Pure Global AI's free database. This Phase 2 trial is sponsored by Qazvin University of Medical Sciences and is currently Recruiting. The study focuses on Malignant neoplasm of breast.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20221126056616N1
Phase 2
Recruiting
drug
Trial Details
Iranian Registry Of Clinical Trial • IRCT20221126056616N1
Investigating and Comparing the Association of Fatty Liver with Tamoxifen and Letrozole in Premenopausal Patients with Breast Cancer
Study Focus
Sponsor & Location
Qazvin University of Medical Sciences
Iran
Timeline & Enrollment
Phase 2
Dec 22, 2022
N/A
ICD-10 Classifications
Malignant neoplasm of breast
Malignant neoplasm of breast
Malignant neoplasm: Breast, unspecified
Malignant neoplasm: Central portion of breast
Personal history of malignant neoplasm of breast
Data Source
Iranian Registry Of Clinical Trial
IRCT20221126056616N1
Non-Device Trial